Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25754863 |
US |
57 | 2 |
Overdose, Acute pulmonary oedema, Suicide attempt, |
||||
AMLODIPINE, |
||||
| 402 | 25754875 |
CN |
27 | 2 |
Overdose, Pancreatitis acute, Toxicity to various agents, |
||||
SERTRALINE, SERTRALINE, |
||||
| 403 | 25754881 |
EU |
61 | 2 |
Toxicity to various agents, Completed suicide, Overdose, Bezoar, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 404 | 25754967 |
BR |
26 | 2 |
Aspiration, Toxicity to various agents, Coma, Myoclonus, Agitation, Overdose, |
||||
BUPROPION, |
||||
| 405 | 25755295 |
IR |
50 | 2 |
Loss of consciousness, Toxicity to various agents, Hypokalaemia, Hypermagnesaemia, Hyponatraemia, Flushing, Hypophosphataemia, Hypocalcaemia, Overdose, Wrong product administered, Product use in unapproved indication, |
||||
MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, |
||||
| 406 | 25755297 |
EU |
66 | 1 |
Toxicity to various agents, Overdose, Depressed level of consciousness, Hepatotoxicity, Hepatic encephalopathy, Blood lactic acid increased, Metabolic acidosis, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 407 | 25755615 |
CA |
2 | |
Hypersensitivity, Intentional product misuse, Prescribed overdose, Product use issue, Hyperhidrosis, Hypertension, Exposure during pregnancy, Overdose, Food allergy, Headache, Immunodeficiency, Dysphagia, Infusion related reaction, Joint swelling, Off label use, Hepatic enzyme increased, Pain, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE, PROGESTERONE, RANITIDINE HYDROCHLORIDE, RITUXIMAB, ALBUTEROL SULFATE, SENNOSIDES, SENNA LEAF, SENNA, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, METHYLPREDNISOLONE, ABATACEPT, |
||||
| 408 | 25755698 |
US |
||
Laryngospasm, Agitation, Bezoar, Drug level increased, Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, NAPROXEN, NAPROXEN SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORATADINE, LORATADINE ORAL, |
||||
| 409 | 25755865 |
GB |
||
Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 410 | 25755908 |
IR |
||
Overdose, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMPHETAMINE, MORPHINE, |
||||
| 411 | 25755915 |
GB |
||
Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 412 | 25756372 |
AU |
47 | 2 |
Stress cardiomyopathy, Suicide attempt, Overdose, Withdrawal syndrome, |
||||
CLONIDINE HYDROCHLORIDE, CLONIDINE, |
||||
| 413 | 25757549 |
US |
1 | |
Toxicity to various agents, Multiple organ dysfunction syndrome, Cardiac dysfunction, Overdose, Drug abuse, Mental disorder, Off label use, |
||||
COLCHICINE, CARVEDILOL, |
||||
| 414 | 25757721 |
IN |
30 | 1 |
Hyperhidrosis, Peripheral coldness, Chest pain, Dizziness, Hypotension, Overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 415 | 25757723 |
VN |
70 | 1 |
Acute respiratory distress syndrome, Non-cardiogenic pulmonary oedema, Coma, Hypotension, Bradycardia, Toxicity to various agents, Overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 416 | 25757725 |
IN |
20 | 2 |
Acute kidney injury, Pleural effusion, Non-cardiogenic pulmonary oedema, Capillary leak syndrome, Hypotension, Overdose, |
||||
AMLODIPINE BESYLATE, |
||||
| 417 | 25757728 |
US |
19 | 2 |
Cardiac dysfunction, Hyperglycaemia, Oliguria, Hypotension, Overdose, Toxicity to various agents, |
||||
AMLODIPINE BESYLATE, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, HYDROXYZINE, |
||||
| 418 | 25766636 |
23 | 1 | |
Dependence, Overdose, |
||||
| 419 | 25748454 |
EU |
91 | 2 |
Interstitial lung abnormality, Hyponatraemia, Overdose, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PANTOPRAZOLE, |
||||
| 420 | 25748692 |
US |
2 | |
Fall, Hallucination, Overdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, OZANIMOD HYDROCHLORIDE, CLOPIDOGREL, DUPILUMAB, MOMETASONE FUROATE, MOMETASONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MIRTAZAPINE, ROSUVASTATIN, RIVASTIGMINE, GABAPENTIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, MELATONIN, CALCIUM, IRON, ARMODAFINIL, |
||||
| 421 | 25748851 |
EU |
61 | 2 |
Stress cardiomyopathy, Overdose, |
||||
MODAFINIL, METHYLPHENIDATE HYDROCHLORIDE, ZOLEDRONIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 422 | 25749384 |
US |
82 | 2 |
Product use in unapproved indication, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 423 | 25749490 |
US |
54 | 1 |
Overdose, Toxicity to various agents, BRASH syndrome, |
||||
METOPROLOL TARTRATE, METOPROLOL, |
||||
| 424 | 25749626 |
EU |
75 | 2 |
Electrocardiogram QT prolonged, Overdose, Accidental overdose, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 425 | 25749789 |
IN |
46 | 1 |
Substance-induced psychotic disorder, Contraindicated product administered, Prescription drug used without a prescription, Overdose, Alcohol intolerance, |
||||
DISULFIRAM, |
||||
| 426 | 25749921 |
US |
78 | 2 |
Seizure, Cataract, Cataract operation, Off label use, Overdose, |
||||
BRIVARACETAM, ZONISAMIDE, ZONISAMIDE, PHENOBARBITAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, |
||||
| 427 | 25749958 |
US |
75 | 1 |
Cerebrovascular accident, Hospitalisation, Overdose, |
||||
LACOSAMIDE, |
||||
| 428 | 25750237 |
EU |
44 | 1 |
Acute kidney injury, Drug interaction, Overdose, |
||||
KETOPROFEN, CARVEDILOL, INSULIN DEGLUDEC AND LIRAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, CLOPIDOGREL, CLOPIDOGREL BISULFATE, EZETIMIBE, LANSOPRAZOLE, |
||||
| 429 | 25750318 |
US |
||
Loss of consciousness, Cerebrovascular accident, Thyroxine decreased, Blood thyroid stimulating hormone increased, Neck pain, Chest pain, Abdominal pain, Product substitution issue, Therapeutic response changed, Overdose, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 430 | 25750325 |
US |
1 | |
Loss of consciousness, Fatigue, Overdose, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 431 | 25750466 |
EU |
61 | 2 |
Stress cardiomyopathy, Overdose, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, MODAFINIL, MODAFINIL, MODAFINIL, MODAFINIL, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 432 | 25750595 |
IN |
||
Maculopathy, Overdose, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 433 | 25751295 |
EU |
||
Hepatotoxicity, Pancreatitis, Hepatic encephalopathy, Hepatorenal syndrome, Coagulopathy, Mental status changes, Toxicity to various agents, Abdominal pain, Nausea, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 434 | 25752106 |
CN |
34 | 2 |
Hepatic function abnormal, Maternal exposure during pregnancy, Overdose, |
||||
IRON SUCROSE, IRON SUCROSE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 435 | 25752534 |
EU |
22 | 1 |
Apnoeic attack, Mental impairment, Tachycardia, Hallucinations, mixed, Infection, Pyrexia, Delirium, Neurological symptom, Seizure, Muscle tone disorder, Extrapyramidal disorder, Sopor, Substance abuse, Drug dependence, Substance dependence, Drug abuse, Overdose, Confusional state, Disorganised speech, Body dysmorphic disorder, Insomnia, |
||||
PREGABALIN, PREGABALIN, BACLOFEN, BACLOFEN, CLONAZEPAM, |
||||
| 436 | 25752579 |
CA |
77 | 2 |
Toxicity to various agents, Balance disorder, Blood calcium decreased, Cognitive disorder, Constipation, Creatinine renal clearance decreased, Creatinine renal clearance increased, Depressed level of consciousness, Drug abuse, Drug interaction, Dyspnoea, Fall, Hypotension, Mobility decreased, Off label use, Overdose, Orthostatic hypotension, Pain, Product use in unapproved indication, Renal function test abnormal, Sedation, Sedation complication, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMINOPHYLLINE, AMINOPHYLLINE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CAFFEINE CITRATE, CAFFEINE CITRATE, CALCIUM, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DOCUSATE SODIUM,SENNOSIDES, ERGOCALCIFEROL, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, GALANTAMINE HYDROBROMIDE, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXCARBAZEPINE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PERPHENAZINE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUININE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, PHOSPHORIC ACID, |
||||
| 437 | 25744342 |
CA |
77 | 2 |
Toxicity to various agents, Balance disorder, Blood calcium decreased, Cognitive disorder, Constipation, Creatinine renal clearance decreased, Creatinine renal clearance increased, Depressed level of consciousness, Drug abuse, Drug interaction, Dyspnoea, Fall, Hypotension, Mobility decreased, Off label use, Overdose, Orthostatic hypotension, Pain, Product use in unapproved indication, Renal function test abnormal, Sedation, Sedation complication, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXCARBAZEPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMINOPHYLLINE, AMINOPHYLLINE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, CYCLOBENZAPRINE, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, ATROPINE SULFATE, ATROPINE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CAFFEINE CITRATE, CALCIUM, CALCIUM CARBONATE, ANTACID, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DIPYRIDAMOLE, DOCUSATE SODIUM,SENNOSIDES, ERGOCALCIFEROL, GALANTAMINE HYDROBROMIDE, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, GLYCERIN, GLYCERIN SUPPOSITORIES, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, LACTULOSE, LACTULOSE, LACTULOSE, LACTULOSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, PERPHENAZINE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUININE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, PHOSPHORIC ACID, |
||||
| 438 | 25744619 |
US |
2 | |
Drug intolerance, Overdose, |
||||
PREDNISONE, |
||||
| 439 | 25744746 |
CA |
||
Colitis ulcerative, Joint stiffness, Inflammation, Pain, Pain in extremity, Malaise, Bone pain, Overdose, Therapy cessation, Treatment delayed, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 440 | 25744795 |
US |
39 | 1 |
Heart rate increased, Skin laceration, Head injury, Haemorrhage, Mucosal dryness, Ecchymosis, Skin abrasion, Compartment syndrome, Leukocytosis, Blood creatinine increased, Hyperkalaemia, Anion gap increased, Blood creatine phosphokinase increased, Sinusitis, Toxicity to various agents, Blood potassium decreased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Lung opacity, Hypoxia, Miosis, Blood pressure decreased, Somnolence, Overdose, |
||||
FENTANYL CITRATE, |
||||
| 441 | 25745102 |
CA |
||
Pain in extremity, Vomiting, Blood pressure decreased, Infusion related reaction, Abdominal pain, Back pain, Chills, Overdose, |
||||
INFLIXIMAB-DYYB, TRIMETHOPRIM, TRIMETHOPRIM, MESALAMINE, |
||||
| 442 | 25745113 |
IN |
1 | |
Drug abuse, Maculopathy, Overdose, |
||||
SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 443 | 25745216 |
GB |
33 | 2 |
Respiratory disorder, Hypotension, Circulatory collapse, Overdose, |
||||
PREGABALIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 444 | 25745220 |
US |
28 | |
Suicide attempt, Overdose, |
||||
BUSPIRONE HYDROCHLORIDE, ISOTRETINOIN, |
||||
| 445 | 25745223 |
GB |
||
Hypotension, Respiratory rate decreased, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PREGABALIN, PREGABALIN, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 446 | 25745226 |
US |
||
Hepatorenal syndrome, Renal tubular necrosis, Acute kidney injury, Hepatotoxicity, Encephalopathy, Toxicity to various agents, Confusional state, Liver injury, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 447 | 25745248 |
US |
1 | |
Tearfulness, Overdose, |
||||
FLUOXETINE HYDROCHLORIDE, |
||||
| 448 | 25745397 |
IR |
||
Overdose, |
||||
MIDAZOLAM HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMPHETAMINE, MORPHINE, |
||||
| 449 | 25745651 |
EU |
27 | 1 |
Intentional overdose, Decreased appetite, Parasomnia, Nightmare, Dry mouth, Back pain, Hyperhidrosis, Headache, Drug use disorder, Insomnia, Withdrawal syndrome, Overdose, |
||||
PREGABALIN, |
||||
| 450 | 25745726 |
EU |
19 | |
Toxicity to various agents, Overdose, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, MORPHINE, |
||||
| 451 | 25745823 |
EU |
||
Overdose, Toxicity to various agents, Depressed level of consciousness, |
||||
PREGABALIN, |
||||
| 452 | 25745842 |
US |
31 | 2 |
Lactic acidosis, Myalgia, Multiple organ dysfunction syndrome, Gastrointestinal toxicity, Leukocytosis, Neutropenia, Thrombocytopenia, Rhabdomyolysis, Overdose, Toxicity to various agents, |
||||
COLCHICINE, |
||||
| 453 | 25745965 |
US |
48 | 2 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 454 | 25746152 |
US |
30 | 1 |
Overdose, Toxicity to various agents, Substance use, |
||||
GABAPENTIN, MORPHINE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 455 | 25746784 |
CH |
58 | 1 |
Acute kidney injury, Treatment noncompliance, Intentional product misuse, Overdose, Nausea, Dizziness, Hypotension, Oedema peripheral, Asthenia, Sinus bradycardia, Toxicity to various agents, Shock, |
||||
AMLODIPINE BESYLATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PREGABALIN, MIRTAZAPINE, LEVOTHYROXINE, EZETIMIBE, ROSUVASTATIN, |
||||
| 456 | 25746801 |
US |
72 | 2 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 457 | 25747974 |
US |
45 | 1 |
Diarrhoea, Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 458 | 25743784 |
US |
44 | 1 |
Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, |
||||
| 459 | 25744163 |
CA |
||
Lacrimation increased, Rhinorrhoea, Chronic obstructive pulmonary disease, Cough, Helicobacter infection, Lower respiratory tract infection, Nasopharyngitis, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 460 | 25742654 |
EU |
||
Malaise, Trismus, Feeling hot, Erythema, Chest pain, Dyspnoea, Overdose, |
||||
INFLIXIMAB, |
||||
| 461 | 25743073 |
US |
71 | 2 |
Overdose, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 462 | 25743089 |
US |
48 | 2 |
Cardiogenic shock, Metabolic acidosis, Intentional self-injury, Overdose, Electrocardiogram QRS complex prolonged, Ventricular tachycardia, Seizure, |
||||
BUPROPION, PROPRANOLOL HYDROCHLORIDE, |
||||
| 463 | 25743106 |
US |
||
Electrocardiogram QRS complex prolonged, Ventricular tachycardia, Cardiogenic shock, Hypotension, Metabolic acidosis, Seizure, Bundle branch block right, Drug ineffective, Overdose, |
||||
BUPROPION, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 464 | 25743174 |
EU |
||
SLE arthritis, Overdose, |
||||
INFLIXIMAB, |
||||
| 465 | 25738146 |
CA |
||
Condition aggravated, Dysmenorrhoea, Faeces discoloured, Skin fissures, Skin haemorrhage, Weight increased, Flatulence, Uveitis, Abdominal pain upper, Arthralgia, Dry skin, Off label use, Intentional product use issue, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 466 | 25738240 |
GB |
48 | 2 |
Overdose, |
||||
PREGABALIN, |
||||
| 467 | 25738242 |
GB |
33 | 2 |
Overdose, |
||||
MORPHINE SULFATE, PREGABALIN, PROMETHAZINE, DEXTROMETHORPHAN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 468 | 25738249 |
GB |
62 | 1 |
Overdose, |
||||
PREGABALIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, |
||||
| 469 | 25738250 |
GB |
38 | 1 |
Overdose, |
||||
OLANZAPINE, PREGABALIN, |
||||
| 470 | 25738252 |
GB |
43 | 1 |
Overdose, |
||||
PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 471 | 25738253 |
GB |
17 | 1 |
Overdose, |
||||
PREGABALIN, OXYCODONE HYDROCHLORIDE, OXYCODONE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 472 | 25738278 |
CA |
||
Condition aggravated, Weight increased, Asthma, Blood pressure fluctuation, Blood pressure increased, Colitis ulcerative, Peripheral swelling, Hypervolaemia, Pain in extremity, Pain in jaw, Peripheral coldness, Oedema peripheral, Chest pain, Dyspnoea, Hypoaesthesia, Paraesthesia, Flushing, Fatigue, Pain, Gastroenteritis viral, Infusion site pain, Inappropriate schedule of product administration, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, VEDOLIZUMAB, METHYLPREDNISOLONE, |
||||
| 473 | 25738531 |
CA |
||
Condition aggravated, Cough, Malaise, Vomiting, Weight increased, Arthralgia, Cardiac failure, Influenza, Nasopharyngitis, Nausea, Incorrect dose administered, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 474 | 25738960 |
CA |
||
Anal fissure, Aphthous ulcer, Condition aggravated, Fistula, Poor venous access, Pyoderma gangrenosum, Uveitis, Abscess, Arthralgia, Eczema, Nausea, Off label use, Intentional product use issue, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 475 | 25738992 |
US |
48 | 2 |
Intentional product misuse, Overdose, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 476 | 25739088 |
US |
61 | 1 |
Overdose, |
||||
TIRZEPATIDE, |
||||
| 477 | 25739212 |
EU |
79 | 1 |
Abscess, Infusion site pain, Fall, Infusion site mass, Malaise, Headache, Hypertension, Overdose, Restlessness, Dyskinesia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 478 | 25739289 |
CA |
||
Weight increased, Anaemia, Condition aggravated, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 479 | 25739359 |
EU |
50 | 2 |
Intestinal haemorrhage, Gastrointestinal inflammation, Overdose, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 480 | 25739391 |
IN |
1 | |
Overdose, Maculopathy, Vision blurred, Photophobia, |
||||
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 481 | 25739422 |
EU |
16 | 2 |
Hepatitis acute, Somnolence, Thrombocytopenia, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 482 | 25739471 |
EU |
||
Blood pressure decreased, Erythema, Fatigue, Overdose, |
||||
INFLIXIMAB, |
||||
| 483 | 25740215 |
US |
1 | |
Toxicity to various agents, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, APREMILAST, |
||||
| 484 | 25740465 |
CA |
||
Condition aggravated, Abdominal abscess, Overdose, |
||||
INFLIXIMAB, AZATHIOPRINE, |
||||
| 485 | 25740928 |
US |
||
Hepatotoxicity, Encephalopathy, Toxicity to various agents, Hyperammonaemia, Coagulopathy, Lethargy, Vomiting, Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 486 | 25740981 |
CA |
||
Blood pressure increased, Anal fistula, Disease recurrence, Pain in extremity, Musculoskeletal stiffness, Swelling, Joint stiffness, Skin exfoliation, Anal abscess, Arthralgia, Dry skin, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, NIRMATRELVIR AND RITONAVIR, |
||||
| 487 | 25741288 |
CA |
||
Condition aggravated, Weight bearing difficulty, Weight decreased, Arthritis, Inflammation, Arthralgia, Inappropriate schedule of product administration, Intentional product use issue, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, NAPROXEN, NAPROXEN SODIUM, PANTOPRAZOLE, PREDNISONE, |
||||
| 488 | 25741344 |
CA |
||
Abdominal discomfort, Abdominal distension, Anal fissure, Apathy, Balance disorder, Blood pressure fluctuation, Condition aggravated, Crying, Disturbance in attention, Erythema nodosum, Eye inflammation, Haemorrhoids, Memory impairment, Mental disorder, Psychiatric symptom, Mouth ulceration, Oral mucosal eruption, Photopsia, Productive cough, Asthenia, Gastrointestinal disorder, Arthralgia, Dizziness, Hypertension, Nasopharyngitis, Oral herpes, Pain, Inappropriate schedule of product administration, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PREDNISONE, PREDNISONE, RAMIPRIL, SERTRALINE, |
||||
| 489 | 25741485 |
US |
56 | 1 |
Arteriosclerosis coronary artery, Toxicity to various agents, Overdose, Nephrosclerosis, Cardiomegaly, Pulmonary congestion, Pulmonary oedema, |
||||
FENTANYL, |
||||
| 490 | 25741487 |
US |
43 | 2 |
Arteriosclerosis coronary artery, Overdose, Toxicity to various agents, Pulmonary congestion, Pulmonary oedema, |
||||
FENTANYL, |
||||
| 491 | 25741493 |
US |
41 | 1 |
Toxicity to various agents, Overdose, Pulmonary oedema, Pulmonary congestion, |
||||
FENTANYL, |
||||
| 492 | 25741494 |
US |
36 | 1 |
Cardiomegaly, Overdose, Toxicity to various agents, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, FENTANYL, |
||||
| 493 | 25741495 |
US |
53 | 1 |
Toxicity to various agents, Overdose, Arteriosclerosis coronary artery, Cardiomegaly, Pulmonary congestion, Pulmonary oedema, |
||||
FENTANYL, |
||||
| 494 | 25741496 |
US |
41 | 2 |
Hypothermia, Overdose, Toxicity to various agents, Cardiac arrest, Pulmonary congestion, Pulmonary oedema, |
||||
FENTANYL, |
||||
| 495 | 25741782 |
EU |
28 | 2 |
Hepatic cytolysis, Overdose, |
||||
IVACAFTOR, |
||||
| 496 | 25742401 |
EU |
20 | 1 |
Suicide attempt, Anxiety, Suicide attempt, Intentional overdose, Sleep disorder, Overdose, Feeling of despair, Suicidal ideation, Toxicity to various agents, Intentional overdose, Thinking abnormal, Apathy, Intentional product misuse, Major depression, Depressed mood, Depression, Condition aggravated, Depression, Depressive symptom, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREGABALIN, PREGABALIN, PREGABALIN, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 497 | 25742475 |
US |
||
Overdose, Inappropriate schedule of product administration, |
||||
INCOBOTULINUMTOXINA, |
||||
| 498 | 25742606 |
CA |
||
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Drug hypersensitivity, Drug intolerance, Erythema, Fatigue, Fluid retention, Foetal death, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Joint swelling, Pain, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Infection, Infusion related reaction, Thrombocytopenia, Upper respiratory tract infection, Contraindicated product administered, Drug ineffective, Intentional product misuse, Maternal exposure during pregnancy, Prescribed overdose, Product use issue, Off label use, Overdose, |
||||
RITUXIMAB, ABACAVIR SULFATE, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, FLUCONAZOLE, FUROSEMIDE, GABAPENTIN, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, PREGABALIN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, TOFACITINIB, |
||||
| 499 | 25733064 |
CA |
1 | |
Haematochezia, Injection site swelling, Abdominal pain upper, Overdose, Off label use, |
||||
INFLIXIMAB, |
||||
| 500 | 25733333 |
CA |
||
Blood pressure increased, Condition aggravated, Excessive cerumen production, Eye haemorrhage, Eye oedema, Hypoacusis, Migraine, Ocular hyperaemia, Ophthalmic migraine, Weight increased, Polyp, Rectal discharge, Stress, Fatigue, Nasopharyngitis, Intentional product use issue, Therapeutic response shortened, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30